Literature DB >> 15138951

Computed tomography features of acute pulmonary tuberculosis.

Chao-Jung Wei1, Chui-Mei Tiu, Jen-Dar Chen, Yi-Hong Chou, Cheng-Yen Chang, Chun Yu.   

Abstract

The purpose of this study was to demonstrate the computed tomography (CT) features of pulmonary tuberculosis in patients with acute clinical manifestations. The emergent CT images of 46 non-AIDS patients with acute clinical presentations of pulmonary tuberculosis (TB) were analyzed. The distribution and characterization of the pulmonary and pleural lesions were specifically focused. Multifocal airspace consolidation in multiple lobes was most commonly seen on the CT in 32 of 46 patients (70%), followed by cavitary pulmonary nodular shadows (50%). Other CT manifestations included pleural effusion (40%), TB empyema (20%), and lymphadenopathy (11%). On followup, 12 patients (26%) developed acute respiratory failure. Patients presenting with multifocal pulmonary consolidation, with or without cavitations, on CT should undergo early pulmonary TB workup. These findings could help early detection for pulmonary TB.

Entities:  

Mesh:

Year:  2004        PMID: 15138951     DOI: 10.1016/j.ajem.2004.02.004

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  3 in total

1.  Chronic necrotising pulmonary aspergillosis: an uncommon aetiology of pneumothorax.

Authors:  François-Pierrick Desgranges; Romain Hernu; François Philit; Laurent Argaud
Journal:  BMJ Case Rep       Date:  2014-09-23

2.  Clinical investigation of cavitary tuberculosis and tuberculous pneumonia.

Authors:  Ki Man Lee; Kang Hyeon Choe; Sung Jin Kim
Journal:  Korean J Intern Med       Date:  2006-12       Impact factor: 2.884

3.  Predictors of Initial Smear-Negative Active Pulmonary Tuberculosis with Acute Early Stage Lung Injury by High-Resolution Computed Tomography and Clinical Manifestations: An Auxiliary Model in Critical Patients.

Authors:  Jun-Jun Yeh
Journal:  Sci Rep       Date:  2019-03-14       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.